English
简体中文
Total: £ 56.28
Published Date: 2025-05-06 | Pages: 87 | Tables: 79 | Medical Devices & Consumables
The global market for Cardiopulmonary Autotransfusion System was valued at US$ 580 million in the year 2024 and is projected to reach a revised size of US$ 683 million by 2031, growing at a CAGR of 2.4% during the forecast period.
Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one"s self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The major players in global Cardiopulmonary Autotransfusion System market include Haemonetics, Medtronic, LivaNova, etc. The top 3 players occupy about 70% shares of the global market. North America and Europe are main markets, they occupy about 80% of the global market. Washed ATS is the main type, with a share about 90%. Heart Surgery is the main application, which holds a share about 35%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Cardiopulmonary Autotransfusion System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiopulmonary Autotransfusion System.
The Cardiopulmonary Autotransfusion System market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiopulmonary Autotransfusion System market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiopulmonary Autotransfusion System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
Segment by Type
Unwashed ATS
Washed ATS
Segment by Application
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cardiopulmonary Autotransfusion System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cardiopulmonary Autotransfusion System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Cardiopulmonary Autotransfusion System Market Overview
1.1 Product Definition
1.2 Cardiopulmonary Autotransfusion System by Type
1.2.1 Global Cardiopulmonary Autotransfusion System Market Value Comparison by Type (2024 VS 2031)
1.2.2 Unwashed ATS
1.2.3 Washed ATS
1.3 Cardiopulmonary Autotransfusion System by Application
1.3.1 Global Cardiopulmonary Autotransfusion System Market Value by Application (2024 VS 2031)
1.3.2 Heart Surgery
1.3.3 Great Organ Transplant Surgery
1.3.4 Other Surgery
1.4 Global Cardiopulmonary Autotransfusion System Market Size Estimates and Forecasts
1.4.1 Global Cardiopulmonary Autotransfusion System Revenue 2020-2031
1.4.2 Global Cardiopulmonary Autotransfusion System Sales 2020-2031
1.4.3 Global Cardiopulmonary Autotransfusion System Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cardiopulmonary Autotransfusion System Market Competition by Manufacturers
2.1 Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cardiopulmonary Autotransfusion System Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cardiopulmonary Autotransfusion System, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Product Type & Application
2.7 Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Date of Enter into This Industry
2.8 Global Cardiopulmonary Autotransfusion System Market Competitive Situation and Trends
2.8.1 Global Cardiopulmonary Autotransfusion System Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cardiopulmonary Autotransfusion System Players Market Share by Revenue
2.8.3 Global Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiopulmonary Autotransfusion System Market Scenario by Region
3.1 Global Cardiopulmonary Autotransfusion System Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cardiopulmonary Autotransfusion System Sales by Region: 2020-2031
3.2.1 Global Cardiopulmonary Autotransfusion System Sales by Region: 2020-2025
3.2.2 Global Cardiopulmonary Autotransfusion System Sales by Region: 2026-2031
3.3 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2020-2031
3.3.1 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2020-2025
3.3.2 Global Cardiopulmonary Autotransfusion System Revenue by Region: 2026-2031
3.4 North America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.4.1 North America Cardiopulmonary Autotransfusion System Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
3.4.3 North America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.5.1 Europe Cardiopulmonary Autotransfusion System Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
3.5.3 Europe Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiopulmonary Autotransfusion System Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiopulmonary Autotransfusion System Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2020-2031)
3.6.3 Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.7.1 Latin America Cardiopulmonary Autotransfusion System Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
3.7.3 Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiopulmonary Autotransfusion System Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiopulmonary Autotransfusion System Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2020-2031)
4.1.1 Global Cardiopulmonary Autotransfusion System Sales by Type (2020-2025)
4.1.2 Global Cardiopulmonary Autotransfusion System Sales by Type (2026-2031)
4.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2031)
4.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2020-2031)
4.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Type (2020-2025)
4.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Type (2026-2031)
4.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2020-2031)
4.3 Global Cardiopulmonary Autotransfusion System Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2020-2031)
5.1.1 Global Cardiopulmonary Autotransfusion System Sales by Application (2020-2025)
5.1.2 Global Cardiopulmonary Autotransfusion System Sales by Application (2026-2031)
5.1.3 Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2031)
5.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2020-2031)
5.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Application (2020-2025)
5.2.2 Global Cardiopulmonary Autotransfusion System Revenue by Application (2026-2031)
5.2.3 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2020-2031)
5.3 Global Cardiopulmonary Autotransfusion System Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Haemonetics
6.1.1 Haemonetics Company Information
6.1.2 Haemonetics Description and Business Overview
6.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Haemonetics Cardiopulmonary Autotransfusion System Product Portfolio
6.1.5 Haemonetics Recent Developments/Updates
6.2 Medtronic
6.2.1 Medtronic Company Information
6.2.2 Medtronic Description and Business Overview
6.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Medtronic Cardiopulmonary Autotransfusion System Product Portfolio
6.2.5 Medtronic Recent Developments/Updates
6.3 LivaNova
6.3.1 LivaNova Company Information
6.3.2 LivaNova Description and Business Overview
6.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
6.3.4 LivaNova Cardiopulmonary Autotransfusion System Product Portfolio
6.3.5 LivaNova Recent Developments/Updates
6.4 Fresenius Kabi
6.4.1 Fresenius Kabi Company Information
6.4.2 Fresenius Kabi Description and Business Overview
6.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Fresenius Kabi Cardiopulmonary Autotransfusion System Product Portfolio
6.4.5 Fresenius Kabi Recent Developments/Updates
6.5 Terumo
6.5.1 Terumo Company Information
6.5.2 Terumo Description and Business Overview
6.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Terumo Cardiopulmonary Autotransfusion System Product Portfolio
6.5.5 Terumo Recent Developments/Updates
6.6 Wandong Health Sources
6.6.1 Wandong Health Sources Company Information
6.6.2 Wandong Health Sources Description and Business Overview
6.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Wandong Health Sources Cardiopulmonary Autotransfusion System Product Portfolio
6.6.5 Wandong Health Sources Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiopulmonary Autotransfusion System Industry Chain Analysis
7.2 Cardiopulmonary Autotransfusion System Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiopulmonary Autotransfusion System Production Mode & Process Analysis
7.4 Cardiopulmonary Autotransfusion System Sales and Marketing
7.4.1 Cardiopulmonary Autotransfusion System Sales Channels
7.4.2 Cardiopulmonary Autotransfusion System Distributors
7.5 Cardiopulmonary Autotransfusion System Customer Analysis
8 Cardiopulmonary Autotransfusion System Market Dynamics
8.1 Cardiopulmonary Autotransfusion System Industry Trends
8.2 Cardiopulmonary Autotransfusion System Market Drivers
8.3 Cardiopulmonary Autotransfusion System Market Challenges
8.4 Cardiopulmonary Autotransfusion System Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Cardiopulmonary Autotransfusion System Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Cardiopulmonary Autotransfusion System Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Cardiopulmonary Autotransfusion System Market Competitive Situation by Manufacturers in 2024
Table 4. Global Cardiopulmonary Autotransfusion System Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Cardiopulmonary Autotransfusion System Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Cardiopulmonary Autotransfusion System Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Cardiopulmonary Autotransfusion System, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Product Type & Application
Table 12. Global Key Manufacturers of Cardiopulmonary Autotransfusion System, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cardiopulmonary Autotransfusion System by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiopulmonary Autotransfusion System as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cardiopulmonary Autotransfusion System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Cardiopulmonary Autotransfusion System Sales by Region (2020-2025) & (K Units)
Table 18. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2020-2025)
Table 19. Global Cardiopulmonary Autotransfusion System Sales by Region (2026-2031) & (K Units)
Table 20. Global Cardiopulmonary Autotransfusion System Sales Market Share by Region (2026-2031)
Table 21. Global Cardiopulmonary Autotransfusion System Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2020-2025)
Table 23. Global Cardiopulmonary Autotransfusion System Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2026-2031)
Table 25. North America Cardiopulmonary Autotransfusion System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
Table 27. North America Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
Table 28. North America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Cardiopulmonary Autotransfusion System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
Table 32. Europe Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
Table 33. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Cardiopulmonary Autotransfusion System Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Cardiopulmonary Autotransfusion System Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Cardiopulmonary Autotransfusion System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Cardiopulmonary Autotransfusion System Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Type (2020-2025)
Table 51. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Type (2026-2031)
Table 52. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2020-2025)
Table 53. Global Cardiopulmonary Autotransfusion System Sales Market Share by Type (2026-2031)
Table 54. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2020-2025)
Table 57. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Type (2026-2031)
Table 58. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Type (2020-2025)
Table 59. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Type (2026-2031)
Table 60. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Application (2020-2025)
Table 61. Global Cardiopulmonary Autotransfusion System Sales (K Units) by Application (2026-2031)
Table 62. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2020-2025)
Table 63. Global Cardiopulmonary Autotransfusion System Sales Market Share by Application (2026-2031)
Table 64. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Cardiopulmonary Autotransfusion System Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2020-2025)
Table 67. Global Cardiopulmonary Autotransfusion System Revenue Market Share by Application (2026-2031)
Table 68. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Application (2020-2025)
Table 69. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Application (2026-2031)
Table 70. Haemonetics Company Information
Table 71. Haemonetics Description and Business Overview
Table 72. Haemonetics Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. Haemonetics Cardiopulmonary Autotransfusion System Product
Table 74. Haemonetics Recent Developments/Updates
Table 75. Medtronic Company Information
Table 76. Medtronic Description and Business Overview
Table 77. Medtronic Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Medtronic Cardiopulmonary Autotransfusion System Product
Table 79. Medtronic Recent Developments/Updates
Table 80. LivaNova Company Information
Table 81. LivaNova Description and Business Overview
Table 82. LivaNova Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. LivaNova Cardiopulmonary Autotransfusion System Product
Table 84. LivaNova Recent Developments/Updates
Table 85. Fresenius Kabi Company Information
Table 86. Fresenius Kabi Description and Business Overview
Table 87. Fresenius Kabi Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Fresenius Kabi Cardiopulmonary Autotransfusion System Product
Table 89. Fresenius Kabi Recent Developments/Updates
Table 90. Terumo Company Information
Table 91. Terumo Description and Business Overview
Table 92. Terumo Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Terumo Cardiopulmonary Autotransfusion System Product
Table 94. Terumo Recent Developments/Updates
Table 95. Wandong Health Sources Company Information
Table 96. Wandong Health Sources Description and Business Overview
Table 97. Wandong Health Sources Cardiopulmonary Autotransfusion System Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Wandong Health Sources Cardiopulmonary Autotransfusion System Product
Table 99. Wandong Health Sources Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Cardiopulmonary Autotransfusion System Distributors List
Table 103. Cardiopulmonary Autotransfusion System Customers List
Table 104. Cardiopulmonary Autotransfusion System Market Trends
Table 105. Cardiopulmonary Autotransfusion System Market Drivers
Table 106. Cardiopulmonary Autotransfusion System Market Challenges
Table 107. Cardiopulmonary Autotransfusion System Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. Product Picture of Cardiopulmonary Autotransfusion System
Figure 2. Global Cardiopulmonary Autotransfusion System Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Cardiopulmonary Autotransfusion System Market Share by Type: 2024 & 2031
Figure 4. Unwashed ATS Product Picture
Figure 5. Washed ATS Product Picture
Figure 6. Global Cardiopulmonary Autotransfusion System Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Cardiopulmonary Autotransfusion System Market Share by Application: 2024 & 2031
Figure 8. Heart Surgery
Figure 9. Great Organ Transplant Surgery
Figure 10. Other Surgery
Figure 11. Global Cardiopulmonary Autotransfusion System Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cardiopulmonary Autotransfusion System Market Size (2020-2031) & (US$ Million)
Figure 13. Global Cardiopulmonary Autotransfusion System Sales (2020-2031) & (K Units)
Figure 14. Global Cardiopulmonary Autotransfusion System Average Price (USD/Unit) & (2020-2031)
Figure 15. Cardiopulmonary Autotransfusion System Report Years Considered
Figure 16. Cardiopulmonary Autotransfusion System Sales Share by Manufacturers in 2024
Figure 17. Global Cardiopulmonary Autotransfusion System Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Cardiopulmonary Autotransfusion System Players: Market Share by Revenue in Cardiopulmonary Autotransfusion System in 2024
Figure 19. Cardiopulmonary Autotransfusion System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Cardiopulmonary Autotransfusion System Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2020-2031)
Figure 22. North America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2020-2031)
Figure 23. U.S. Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 24. Canada Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Europe Cardiopulmonary Autotransfusion System Sales Market Share by Country (2020-2031)
Figure 26. Europe Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2020-2031)
Figure 27. Germany Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. France Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. U.K. Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Italy Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Russia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Asia Pacific Cardiopulmonary Autotransfusion System Sales Market Share by Region (2020-2031)
Figure 33. Asia Pacific Cardiopulmonary Autotransfusion System Revenue Market Share by Region (2020-2031)
Figure 34. China Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. Japan Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. South Korea Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. India Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Australia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. China Taiwan Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Indonesia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Thailand Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Malaysia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 43. Latin America Cardiopulmonary Autotransfusion System Sales Market Share by Country (2020-2031)
Figure 44. Latin America Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2020-2031)
Figure 45. Mexico Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Brazil Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Argentina Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 48. Middle East and Africa Cardiopulmonary Autotransfusion System Sales Market Share by Country (2020-2031)
Figure 49. Middle East and Africa Cardiopulmonary Autotransfusion System Revenue Market Share by Country (2020-2031)
Figure 50. Turkey Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Saudi Arabia Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. UAE Cardiopulmonary Autotransfusion System Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 53. Global Sales Market Share of Cardiopulmonary Autotransfusion System by Type (2020-2031)
Figure 54. Global Revenue Market Share of Cardiopulmonary Autotransfusion System by Type (2020-2031)
Figure 55. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Type (2020-2031)
Figure 56. Global Sales Market Share of Cardiopulmonary Autotransfusion System by Application (2020-2031)
Figure 57. Global Revenue Market Share of Cardiopulmonary Autotransfusion System by Application (2020-2031)
Figure 58. Global Cardiopulmonary Autotransfusion System Price (USD/Unit) by Application (2020-2031)
Figure 59. Cardiopulmonary Autotransfusion System Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
